glp-1 miracle drug The revolution: What UAB researchers are discovering about how these drugs work Are the New Weight Loss

CKD affects approximately 37 million adults in the US and is a common complication of diabetes, with approximately 40% of people with type 2 going on to develop the condition

Incretin pharmacology: a review of the incretin effect and current incretin-based therapies

Kostev K, Ouwens M, Grandy S, Johnsson KM, Qiao Q

Popular weight loss drugs such as semaglutide (Ozempic, Wegovy, and Rybelsus) and tirzepatide (Mounjaro and Zepbound) may do more than help people lose weight

Understanding which category you fall into requires looking at the evidence, your personal history, and your metabolic response

Ozempic Ozempic is available in doses of 2 mg to 8 mg in once-weekly injections